Citation: D. Nguyen et al., IDEC-C2B8 ANTI-CD20 PHASE-II TRIAL - RESULTS ON BONE-MARROW AND PERIPHERAL-BLOOD TUMOR RESPONSE IN PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) LYMPHOPROLIFERATIVE DISORDERS (LPD)/, Blood, 90(10), 1997, pp. 2277-2277